N-[(2-chlorophenyl)methyl]-4-[[5-(2-oxo-1H-pyridin-4-yl)imidazo[1,2-a]pyridin-8-yl]amino]benzamide;N-cyclopentyl-4-[[5-(1H-pyrazol-4-yl)imidazo[1,2-a]pyridin-8-yl]amino]benzamide;N-cyclopropyl-4-[[5-(2-oxo-1H-pyridin-4-yl)imidazo[1,2-a]pyridin-8-yl]amino]benzamide;4-[8-(3-methylsulfonylanilino)imidazo[1,2-a]pyridin-5-yl]-1H-pyridin-2-one
C89H77ClN20O8S — CID 158446666
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[(2-chlorophenyl)methyl]-4-[[5-(2-oxo-1H-pyridin-4-yl)imidazo[1,2-a]pyridin-8-yl]amino]benzamide;N-cyclopentyl-4-[[5-(1H-pyrazol-4-yl)imidazo[1,2-a]pyridin-8-yl]amino]benzamide;N-cyclopropyl-4-[[5-(2-oxo-1H-pyridin-4-yl)imidazo[1,2-a]pyridin-8-yl]amino]benzamide;4-[8-(3-methylsulfonylanilino)imidazo[1,2-a]pyridin-5-yl]-1H-pyridin-2-one
N-[(2-chlorophenyl)methyl]-4-[[5-(2-oxo-1H-pyridin-4-yl)imidazo[1,2-a]pyridin-8-yl]amino]benzamide;N-cyclopentyl-4-[[5-(1H-pyrazol-4-yl)imidazo[1,2-a]pyridin-8-yl]amino]benzamide;N-cyclopropyl-4-[[5-(2-oxo-1H-pyridin-4-yl)imidazo[1,2-a]pyridin-8-yl]amino]benzamide;4-[8-(3-methylsulfonylanilino)imidazo[1,2-a]pyridin-5-yl]-1H-pyridin-2-one (PubChem CID 158446666) has the molecular formula C89H77ClN20O8S and a molecular weight of 1622.25 g/mol. Its IUPAC name is N-[(2-chlorophenyl)methyl]-4-[[5-(2-oxo-1H-pyridin-4-yl)imidazo[1,2-a]pyridin-8-yl]amino]benzamide;N-cyclopentyl-4-[[5-(1H-pyrazol-4-yl)imidazo[1,2-a]pyridin-8-yl]amino]benzamide;N-cyclopropyl-4-[[5-(2-oxo-1H-pyridin-4-yl)imidazo[1,2-a]pyridin-8-yl]amino]benzamide;4-[8-(3-methylsulfonylanilino)imidazo[1,2-a]pyridin-5-yl]-1H-pyridin-2-one.
Molecular Properties
| Compound Name | N-[(2-chlorophenyl)methyl]-4-[[5-(2-oxo-1H-pyridin-4-yl)imidazo[1,2-a]pyridin-8-yl]amino]benzamide;N-cyclopentyl-4-[[5-(1H-pyrazol-4-yl)imidazo[1,2-a]pyridin-8-yl]amino]benzamide;N-cyclopropyl-4-[[5-(2-oxo-1H-pyridin-4-yl)imidazo[1,2-a]pyridin-8-yl]amino]benzamide;4-[8-(3-methylsulfonylanilino)imidazo[1,2-a]pyridin-5-yl]-1H-pyridin-2-one |
|---|---|
| PubChem CID | 158446666 |
| Molecular Formula | C89H77ClN20O8S |
| Molecular Weight | 1622.25 g/mol |
| Exact Mass | 1620.56 |
| IUPAC Name | N-[(2-chlorophenyl)methyl]-4-[[5-(2-oxo-1H-pyridin-4-yl)imidazo[1,2-a]pyridin-8-yl]amino]benzamide;N-cyclopentyl-4-[[5-(1H-pyrazol-4-yl)imidazo[1,2-a]pyridin-8-yl]amino]benzamide;N-cyclopropyl-4-[[5-(2-oxo-1H-pyridin-4-yl)imidazo[1,2-a]pyridin-8-yl]amino]benzamide;4-[8-(3-methylsulfonylanilino)imidazo[1,2-a]pyridin-5-yl]-1H-pyridin-2-one |
| SMILES | CS(=O)(=O)c1cccc(Nc2ccc(-c3cc[nH]c(=O)c3)n3ccnc23)c1.O=C(NC1CC1)c1ccc(Nc2ccc(-c3cc[nH]c(=O)c3)n3ccnc23)cc1.O=C(NC1CCCC1)c1ccc(Nc2ccc(-c3cn[nH]c3)n3ccnc23)cc1.O=C(NCc1ccccc1Cl)c1ccc(Nc2ccc(-c3cc[nH]c(=O)c3)n3ccnc23)cc1 |
| InChI | InChI=1S/C26H20ClN5O2.C22H22N6O.C22H19N5O2.C19H16N4O3S/c27-21-4-2-1-3-19(21)16-30-26(34)17-5-7-20(8-6-17)31-22-9-10-23(32-14-13-29-25(22)32)18-11-12-28-24(33)15-18;29-22(27-17-3-1-2-4-17)15-5-7-18(8-6-15)26-19-9-10-20(16-13-24-25-14-16)28-12-11-23-21(19)28;28-20-13-15(9-10-23-20)19-8-7-18(21-24-11-12-27(19)21)25-16-3-1-14(2-4-16)22(29)26-17-5-6-17;1-27(25,26)15-4-2-3-14(12-15)22-16-5-6-17(23-10-9-21-19(16)23)13-7-8-20-18(24)11-13/h1-15,31H,16H2,(H,28,33)(H,30,34);5-14,17,26H,1-4H2,(H,24,25)(H,27,29);1-4,7-13,17,25H,5-6H2,(H,23,28)(H,26,29);2-12,22H,1H3,(H,20,24) |
| InChIKey | HDLYQCXCOWAQEO-UHFFFAOYSA-N |
| XLogP | 15.32 |
| TPSA | 366.02 Ų |
| H-Bond Donors | 11 |
| H-Bond Acceptors | 21 |
| Rotatable Bonds | 20 |
| Heavy Atoms | 119 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1622.25 |
| LogP ≤ 5 | 15.32 |
| H-Bond Donors ≤ 5 | 11 |
| H-Bond Acceptors ≤ 10 | 21 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158446666 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.